Twinrab 1500Iu/2.5Ml Inj is a combination medicine that belongs to the class of monoclonal antibodies. It is used in post-exposure rabies prophylaxis (prevention). Rabies is a viral disease spread through contact with infected animal saliva, usually through bites, scratches, or licks on broken skin. Symptoms include pain or itching at the bite site, fever, fear of water, and sensitivity to noise, light, and air.
Twinrab 1500Iu/2.5Ml Inj contains Docaravimab and Miromavimab as its active components. It works by binding to the rabies virus and neutralizing it, providing immediate passive immunity to individuals exposed to the virus.
Twinrab 1500Iu/2.5Ml Inj will be administered by a healthcare professional; do not self-administer. Common side effects of Twinrab 1500Iu/2.5Ml Inj include injection site reactions such as pain, swelling, redness, and a low-grade fever. Most of these side effects do not require medical attention and gradually resolve over time. However, please contact your doctor if these side effects persist or worsen.
Before starting treatment with Twinrab 1500Iu/2.5Ml Inj, inform your doctor if you are allergic to any of its components. Consult your doctor if you are breastfeeding or pregnant. Twinrab 1500Iu/2.5Ml Inj is recommended for children and older adults only if prescribed by a doctor, as its effects are not fully established. Let your doctor know if you have any pre-existing medical conditions or liver/kidney diseases before receiving Twinrab 1500Iu/2.5Ml Inj.